doi:10.3389/fcvm.2024.1288659 Akkus NI, Abdulbaki A, Jimenez E, Tandon N
Ingredients Water (Aqua) Glycerin Copper Tripeptide-1 (1% GHK-Cu) Phenoxyethanol Palmitoyl Tripeptide-1 Palmitoyl Tetrapeptide-7 Six ingredients total
doi:10.1073/pnas.85.8.2464 43
Lab Requirements Most providers require baseline lab work before or shortly after starting GLP-1 medication
With increasing frequency over the past few years, optometrists across the country have gotten referrals from internists requesting baseline diabetic retinopathy (DR) screenings for patients about to start therapy with one of the glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists such as semaglutide (Ozempic, Novo Nordisk), tirzepatide (Mounjaro, Eli Lilly) and dulaglutide (Trulicity, Eli Lilly
doi: 10.1021/acsinfecdis.0c00288